11.07.2015 Views

Pathology of the Head and Neck

Pathology of the Head and Neck

Pathology of the Head and Neck

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Lesions <strong>of</strong> Squamous Epi<strong>the</strong>lium Chapter 1 21Fig. 1.17. Basaloid squamous cell carcinoma.a Closely packed basaloid cells with hyperchromaticnuclei <strong>and</strong> scant cytoplasm,with focal peripheral palisading <strong>of</strong> nuclei.b Abrupt transition between squamous <strong>and</strong>basaloid cells. c Focal squamous differentiationin adenoid cystic carcinoma. Courtesy<strong>of</strong> Dr. Pieter J. Slootwegabc1.3.6.3 Differential DiagnosisDifferential diagnosis includes neuroendocrine carcinoma,adenoid cystic carcinoma, adenocarcinoma <strong>and</strong>adenosquamous carcinoma.Neuroendocrine carcinomas express various neuroendocrinemarkers that help to distinguish neuroendocrinecarcinomas from BSCCs. However, as 60–75%<strong>of</strong> cases <strong>of</strong> BSCC have been reported to express neurone-specificenolase [19, 65, 318] <strong>the</strong> application <strong>of</strong> o<strong>the</strong>rneuroendocrine markers, including chromogranin,CD56, <strong>and</strong> synaptophysin, is advised [19, 65].Adenoid cystic carcinomas, especially <strong>the</strong> solid variant,may resemble BSCCs but adenoid cystic carcinomasrarely show squamous differentiation (Fig. 1.17C). Immunohistochemistrymay also be helpful: tumour cellsin adenoid cystic carcinomas express S-100 protein <strong>and</strong>vimentin, while tumour cells in BSCCs usually do notexpress ei<strong>the</strong>r <strong>of</strong> <strong>the</strong> two markers [21, 195].Adenocarcinomas <strong>and</strong> adenosquamous carcinomascan be distinguished from BSCCs by <strong>the</strong> presence<strong>of</strong> gl<strong>and</strong> formation <strong>and</strong> mucin secretion within <strong>the</strong> tumourcells.1.3.6.4 Treatment <strong>and</strong> PrognosisA BSCC is an aggressive, rapidly growing tumour characterisedby an advanced stage at <strong>the</strong> time <strong>of</strong> diagnosis <strong>and</strong>a poor prognosis. Metastases to <strong>the</strong> regional lymph nodeshave been reported in two-thirds <strong>of</strong> patients [19, 195, 277,293], <strong>and</strong> distant metastases involving lungs, bone, skin<strong>and</strong> brain in 37–50% <strong>of</strong> patients [19, 195, 293].It is generally believed that BSCCs are more aggressivethan conventional SCCs [103, 108, 195, 372, 377].However, some studies indicate that BSCCs exhibit behavioursimilar to that <strong>of</strong> high-grade conventional SCCs<strong>of</strong> <strong>the</strong> head <strong>and</strong> neck [19, 134, 222, 376].The treatment <strong>of</strong> choice is radical surgical excision<strong>and</strong>, because <strong>of</strong> early regional lymph node <strong>and</strong> distantvisceral metastases, radical neck dissection <strong>and</strong> supplementaryradio- <strong>and</strong> chemo<strong>the</strong>rapy [21, 372, 375].

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!